Ledyard National Bank increased its holdings in Danaher Co. (NYSE:DHR – Free Report) by 5.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,503 shares of the conglomerate’s stock after purchasing an additional 299 shares during the quarter. Ledyard National Bank’s holdings in Danaher were worth $1,321,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Silicon Valley Capital Partners bought a new position in shares of Danaher during the first quarter valued at approximately $29,000. Raleigh Capital Management Inc. increased its position in shares of Danaher by 68.9% during the first quarter. Raleigh Capital Management Inc. now owns 125 shares of the conglomerate’s stock valued at $32,000 after buying an additional 51 shares during the period. America First Investment Advisors LLC bought a new position in Danaher in the first quarter worth about $34,000. Beacon Capital Management LLC lifted its holdings in Danaher by 39.4% in the second quarter. Beacon Capital Management LLC now owns 216 shares of the conglomerate’s stock worth $52,000 after buying an additional 61 shares during the period. Finally, Ogorek Anthony Joseph NY ADV bought a new stake in Danaher during the 1st quarter valued at approximately $64,000. 76.71% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Danaher news, SVP Jose-Carlos Gutierrez-Ramos sold 590 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $250.54, for a total transaction of $147,818.60. Following the completion of the transaction, the senior vice president now owns 6,939 shares in the company, valued at approximately $1,738,497.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is owned by company insiders.
Danaher Price Performance
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, October 24th. The conglomerate reported $2.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.83 by $0.19. Danaher had a return on equity of 13.71% and a net margin of 20.01%. The firm had revenue of $6.87 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter last year, the business posted $2.56 earnings per share. The firm’s revenue was down 10.3% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Co. will post 8.36 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. The ex-dividend date was Wednesday, October 11th. Danaher’s dividend payout ratio (DPR) is presently 13.62%.
Wall Street Analysts Forecast Growth
DHR has been the topic of several research reports. Bank of America boosted their price objective on shares of Danaher from $250.00 to $280.00 in a research note on Wednesday, July 26th. StockNews.com started coverage on shares of Danaher in a report on Wednesday. They set a “buy” rating on the stock. Stifel Nicolaus decreased their price objective on shares of Danaher from $250.00 to $240.00 and set a “hold” rating for the company in a report on Wednesday, July 26th. Raymond James cut their target price on Danaher from $250.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 25th. Finally, Royal Bank of Canada lowered their price target on Danaher from $246.00 to $239.00 and set an “outperform” rating on the stock in a report on Wednesday, October 25th. Three analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $257.73.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.
- Five stocks we like better than Danaher
- Trading Halts Explained
- Is it time to buy the dip in Walmart shares?
- When to Sell a Stock for Profit or Loss
- Unlocking AI investment opportunities in healthcare
- How to Invest in Blue Chip Stocks
- New Disney investor propels stock to ranks of best S&P gainers
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.